Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

This report analyzes how leading pharmaceutical companies in Europe utilize the medical liaison function.  Based on interviews with present and former employees of the target organizations, this report analyzes the target companies from the following perspectives:

–        Strategic approach to the medical liaison function

–        Organizational structure/reporting relationships by title

–        Distribution of personnel by business unit/therapeutic area

–        Number of personnel by title

–        Key roles by title

–        Target and common backgrounds by title

–        Typical salary range by title

–        Description of incentive package by title

–        Evaluation methods

For companies interested in this same type of information on a global scale, a comparable study analyzes the medical liaison function in the United States. 

This one-of-a-kind report captures the responses of over 100 practicing oncologists in the United States – as they are asked to rate the effectiveness of leading oncology sales forces in regard to the following attributes:
 

We not only capture the revealing survey results, but PharmaForce digs deeper by conducting targeted interviews with members of the “best” and “worst” performing sales forces to uncover the reasons for their rankings.

This program analyzes in detail the marketing expenditures of leading oncology franchises in the top five countries in Europe (i.e., France, Germany, Italy, Spain and the United Kingdom).  The key expenditures benchmarked include:

 
Analysis of the sales and marketing organizations includes:

* Save 5% -- Mention "PharmCast.com" when purchase.

To receive more information about the study, please click on the following "Request for Info" link.